Your session is about to expire
← Back to Search
Shock Wave Therapy
Shockwave Treatment for Connective Tissue Disorder
N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days post treatment
Awards & highlights
Study Summary
This trialstudies a device to assess the effectiveness of shock wave treatment for medical purposes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days post treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
# of Subjects With Altered Gene Expression
Trial Design
1Treatment groups
Experimental Treatment
Group I: Shockwave DeviceExperimental Treatment1 Intervention
The Shockwave device will be used on multiple areas of the body for the purpose of treating connective tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shockwave Treatment
2021
N/A
~10
Find a Location
Who is running the clinical trial?
Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,231 Total Patients Enrolled
Jennifer CiviokStudy DirectorCynosure, Inc.
16 Previous Clinical Trials
487 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger